

Congressional Record, Volume 163 Issue 56 (Thursday, March 30, 2017)

[Congressional Record Volume 163, Number 56 (Thursday, March 30, 2017)]
[House]
[Pages H2595-H2596]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                     EXECUTIVE COMMUNICATIONS, ETC.

  Under clause 2 of rule XIV, executive communications were taken from 
the Speaker's table and referred as follows:


[[Page H2596]]


  

       940. A letter from the Acting Secretary of the Army, 
     Department of Defense, transmitting the Annual Report to 
     Congress on the Activities of the Western Hemisphere 
     Institute for Security Cooperation for 2016, pursuant to 10 
     U.S.C. 2166(i); Public Law 106-398, Sec. 1 (as amended by 
     Public Law 107-314, Sec. 932(a)(1)); (116 Stat. 2625); to the 
     Committee on Armed Services.
       941. A letter from the Acting Under Secretary for 
     Acquisition, Technology, and Logistics, Department of 
     Defense, transmitting the Department of Defense Chemical 
     Demilitarization Program Semi-Annual Report to Congress for 
     March 2017, pursuant to 50 U.S.C. 1521(j); Public Law 99-145, 
     Sec. 1412 (as amended by Public Law 112-239, Sec. 1421(a)); 
     (126 Stat. 204); to the Committee on Armed Services.
       942. A letter from the Secretary, Department of Defense, 
     transmitting a letter authorizing five officers to wear the 
     insignia of the grade of brigadier general, pursuant to 10 
     U.S.C. 777(b)(3)(B); Public Law 104-106, Sec. 503(a)(1) (as 
     added by Public Law 108-136, Sec. 509(a)(3)); (117 Stat. 
     1458); to the Committee on Armed Services.
       943. A letter from the Assistant Administrator, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's final rule -- 
     Schedules of Controlled Substances: Placement of Brivaracetam 
     Into Schedule V [Docket No.: DEA-435] received March 28, 
     2017, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, 
     Sec. 251; (110 Stat. 868); to the Committee on Energy and 
     Commerce.
       944. A letter from the Assistant Administrator, Diversion 
     Control Division, Drug Enforcement Administration, Department 
     of Justice, transmitting the Department's interim final rule 
     -- Schedules of Controlled Substances: Placement of FDA-
     Approved Products of Oral Solutions Containing Dronabinol 
     [(--)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)] in 
     Schedule II [Docket No.: DEA-344] received March 28, 2017, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); to the Committee on Energy and 
     Commerce.
       945. A letter from the Auditor, Office of the District of 
     Columbia Auditor, transmitting a report entitled, ``DHCD 
     Should Improve Management of the Housing Production Trust 
     Fund to Better Meet Affordable Housing Goals'', pursuant to 
     Public Law 93-198, Sec. 455(d); (87 Stat. 803); to the 
     Committee on Oversight and Government Reform.
       946. A letter from the Auditor, Office of the District of 
     Columbia Auditor, transmitting a report entitled, ``Internal 
     Control Weaknesses Found in the Marion S. Barry Summer Youth 
     Employment Program'', pursuant to Public Law 93-198, Sec. 
     455(d); (87 Stat. 803); to the Committee on Oversight and 
     Government Reform.
       947. A letter from the Assistant Director for Legislative 
     Affairs, Consumer Financial Protection Bureau, transmitting 
     the Bureau's FY 2016 No FEAR Act report, pursuant to 5 U.S.C. 
     2301 note; Public Law 107-174, 203(a) (as amended by Public 
     Law 109-435, Sec. 604(f)); (120 Stat. 3242); to the Committee 
     on Oversight and Government Reform.
       948. A letter from the Associate General Counsel for 
     General Law, Office of the General Counsel, Department of 
     Homeland Security, transmitting a notification of designation 
     of acting officer and a notification of discontinuation of 
     service in acting role, pursuant to 5 U.S.C. 3349(a); Public 
     Law 105-277, 151(b); (112 Stat. 2681-614); to the Committee 
     on Oversight and Government Reform.
       949. A letter from the EEO Director, Office of Civil Rights 
     and Equal Opportunity, Social Security Administration, 
     transmitting the Administration's FY 2016 No FEAR Act report, 
     pursuant to 5 U.S.C. 2301 note; Public Law 107-174, 203(a) 
     (as amended by Public Law 109-435, Sec. 604(f)); (120 Stat. 
     3242); to the Committee on Oversight and Government Reform.
       950. A letter from the Acting Assistant Attorney General, 
     Department of Justice, transmitting a report entitled, ``Debt 
     Collection Recovery Activities of the Department of Justice 
     for Civil Debts Referred for Collection Annual Report for 
     Fiscal Year 2016'', pursuant to 31 U.S.C. 3718(c); Public Law 
     97-452, Sec. 1(16)(A) (as amended by Public Law 99-578, Sec. 
     1(4)); (100 Stat. 3305); to the Committee on the Judiciary.
       951. A letter from the Staff Director, United States 
     Sentencing Commission, transmitting a report on the 
     compliance of the federal district courts with documentation 
     submission requirements of 28 U.S.C. 994(w)(1), pursuant to 
     28 U.S.C. 994(w)(3); to the Committee on the Judiciary.
       952. A letter from the Acting Assistant Attorney General, 
     Office of Legislative Affairs, Department of Justice, 
     transmitting notification that the Department takes no 
     position on enactment of H.R. 654, the Pacific Northwest 
     Earthquake Preparedness Act of 2017; to the Committee on 
     Transportation and Infrastructure.

                          ____________________



